NEW YORK, March 8 - Leslie Misrock, a 73 year-old partner at Pennie & Edmonds in New York who has been called the father of Biotechnology Patent Law, is concerned about proteomics. With decades of biotechnology litigation under his belt, Misrock has warned industry leaders that battles over protein patents could stop proteomics dead in its tracks. This week, Genomeweb caught up with Misrock to discuss this issue.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.